MedTrace Logo

Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes

NCT00547001 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2008-07-18

No results posted yet for this study

Summary

This study will evaluate whether there is a difference in the proportion of women who report a worsening severity of their hot flashes between three tapering schedules for one accepted HT/ET regimen. Secondarily, we hope to evaluate whether there is a difference in the frequency (number of occurrences per week), severity (defined as a subjective scale mild, moderate, or severe), and "Severity Index" (SI, equaling the product of both) of hot flashes between three tapering schedules for one accepted HT/ET regimen.

Conditions

Interventions

DRUG

Estradiol

1mg during stabilization \& then a taper to 0.75mg, 0.5mg, 0.25mg, 0.125mg.

Sponsors & Collaborators

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Peter F. Schnatz, D.O. · Hartford Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00547001 on ClinicalTrials.gov